所属 医学部 医学科（東京女子医科大学病院） 職種 客員教授
|発表タイトル||Benefit of Sinus Rhythm Restoration in Heart failure Patients with Atrial Tachyarrhythmia Treated with Landiolol|
|発表者・共同発表者||◎松井優子, 坂井政之, 鈴木敦, 志賀剛, 萩原誠久|
|概要||*Poster Session (Japanese)92 AF, Medicine
Atrial tachyarrhythmias (ATA) are frequently observed in patients with heart failure (HF). We evaluated the rates and benefits of sinus rhythm (SR) restoration among patients HF with ATA treated with ultrashort acting intravenous beta1- blocker, landiolol. We studied 67 consecutive HF patients with ATA (age: 67 ± 12 years, 36 male) treated with landiolol from May 2014 to December 2017 at Tokyo Women´s Medical University Hospital. The median maintenance dose of landiolol was 3.0 (1.0-12.0) µ/kg/min and the median treatment duration of landiolol was 5 (1-24) days. Eight patients experienced in-hospital death. Forty-one (69%) of 59 patients discharged alive were in SR. During the followup period of 16 ±12 months, 4 patients died and 12 patients experienced rehospitalization due to worsening HF after hospital discharge. There was a significant higher rate of death or HF rehospitalization in patients without SR restoration than patients with SR restoration (44% vs. 20%) (Figure). We should consider that the benefits of rhythm control in patients with HF and ATA.